Filter posts

Washington Post: Gene Therapies Offer “Dramatic Promise”

Yesterday’s Washington Post has an in-depth article about gene therapy, a type of therapeutic intervention which …

Check Out This Op-Ed from PA Bio

Make sure to check out the op-ed that Christopher P. Molineaux, President and CEO of …

A National Blueprint for Biodefense Released Today

A major report was released today detailing findings and recommendations to improve the U.S. biodefense …

Setting the Record Straight on Innovation and Drug Development

Modern biotechnology is a relatively young industry, but in just over 40 years, the entrepreneurs, …

Mesothelioma: Once Hopeless Cancer, on the Verge of Promising Advances

Mesothelioma, the word, (pronounced mez-uh-thee-lee-oh-muh) is often much better known than the illness it represents. …

Biotech Policy Outlook at #BIF15: 21st Century Cures, IPR, TPP, and PDUFA VI

To even the most casual observer, 2015 has been a big year in the biotech …

Roll Call: Patient-Centeredness, Comparative Effectiveness, and Value

In Roll Call, Tony Coelho former House Majority Whip, Chairman of the Partnership to Improve …

Wall Street Journal: Patients Deserve Better

In case you missed it, The Wall Street Journal published my Letter to the Editor …

Emerging Themes in Personalized Medicine

The adoption of Personalized Medicine is being driven by the omnipresence of Next-Generation Sequencing (NGS), …

WSJ Article Cherry Picks Cost, Ignores Value of Medicines

Today’s Wall Street Journal story, “Price Increases Drive Drug Firms’ Revenue” reaffirms that old chestnut, …